IPRSquare recruits Byeongguk An, former Daewoo Securities Research Center head... Expanding IPO consulting business

IPR Square, a specialized IR and PR consulting firm led by CEO Namgu Lee, announced on the 3rd that it is officially expanding its IPO (Initial Public Offering) consulting business by appointing Byeongguk Ahn, former Head of the Daewoo Securities Research Center, as a management advisor.

Byeongguk Ahn, former Head of the Daewoo Securities Research Center, is known as a veteran in the securities industry. He joined Daewoo Securities in 1990 and has served as the Head of the Daewoo Securities Research Center, specializing in financial market and corporate research and analysis. Joining IPR Square, which has been intensifying its IPO consulting business, he is expected to bring a fresh breeze to the IR and IPO consulting industry based on his extensive experience and expertise.

IPR Square recently successfully conducted IPOs for S-Biomedics and Secuzen. S-Biomedics attracted attention from the bio industry and investors by setting a continuous 'hit' record during the listing process. In the demand forecast for institutional investors held on April 17-18, it showed a competition rate of 854 to 1 and finalized the offering price at 18,000 KRW, the top of the desired offering price band. In the general public subscription, it achieved a 'subscription deposit of 1.7 trillion KRW' and a 'competition rate of 995 to 1.' On the first day of listing on May 4, the stock price reached 24,000 KRW, 33.3% higher than the offering price during trading hours.

Secuzen recorded an even more explosive success. In the demand forecast for institutional investors held on June 14-15, it showed a competition rate of 1,801 to 1 and finalized the offering price at 3,000 KRW, exceeding the top of the desired offering price band. In the general public subscription, it achieved a 'competition rate of 1,932 to 1,' marking the highest subscription competition rate in the first half of this year. On the first day of listing on June 29, the stock price surged to 11,800 KRW during trading hours, 293.3% higher than the offering price, showing a strong performance.

Representatives from S-Biomedics and Secuzen stated that from the moment they passed the preliminary review request to the demand forecast, general public subscription, and entry into the KOSDAQ market, they moved as one and received systematic and comprehensive IR and PR services. Following their successful IPOs, both companies plan to continue collaborating to enhance corporate value through IPR Square’s IR and PR consulting services.

IPR Square was established in 2010 as a specialized IR and PR consulting firm. It provides services such as IR, domestic and international media publicity, disclosure advisory, and IPO consulting for listed and unlisted companies in Korea. It also actively participates in social contribution activities by running a talent donation 'Mentor Support Program' offering management advice and PR consulting for startups and promising new ventures. The company plans to further solidify its position as an IR and PR consulting firm by expanding its IPO business.

Namgu Lee, CEO of IPR Square, said, “We are pleased to achieve good results in the IPO market amid ongoing corporate value uncertainties due to stock market volatility,” adding, “With the appointment of Byeongguk Ahn, former Head of the Daewoo Securities Research Center, we will provide more advanced services in the IPO market through upgraded IR consulting and actively expand our business.”

This content was produced with the assistance of AI translation services.